3 Promising Small-Cap Biotech Neurology Stocks

While biotech stocks as a whole remain under pressure from interest rate concerns, today’s article highlights three promising small-cap biotech stocks in the neurology space to consider, especially as the dominant thesis for conditions such as Alzheimer’s and dementia has been losing appeal and new approaches are being sought. For a detailed look at these three biotech neurology stocks, CLICK HERE.